ATLANTA, December 17, 2019 – ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures (FGP), today announced several additions to its leadership team. Joining are Peter Pizzo as chief financial officer, Amy Lazarus as vice president of USA operations, and Sean Finnerty and Tim Hein as area vice presidents of sales. The industry veterans bring considerable experience leading businesses and introducing new products in the medical device industry.
“2019 was a significant year for ControlRad, with FDA clearance and initial installations of our first product,” says Guillaume Bailliard, ControlRad chief executive officer. “The wealth of experience that Peter, Amy, Sean and Tim bring in introducing new products to the market will be invaluable as we ramp up commercialization for ControlRad Trace in 2020.”
ControlRad Trace is a recently FDA-cleared technology that can be integrated into existing mobile C-arms to reduce radiation in any FGP. It reduces radiation exposure by a minimum of 50% and up to 89%, protecting patients and medical staff without compromising image quality or workflow.1
Peter Pizzo, Chief Financial Officer
Pizzo has more than 25 years of experience in senior financial roles with venture-backed and public life science companies. Most recently, he served as CFO of Cartiva, Inc. until its purchase by Wright Medical. Previously, he was CFO of Proxima Therapeutics, Inc., and Serologicals Corporation. He currently serves on the board of directors of Alimera Sciences, Inc., where he chairs the audit committee and is a member of the nominating and corporate governance committee. He earned his bachelor’s degree in business administration/accounting from Washington and Lee University in Lexington, Virginia.
Amy Lazarus, Vice President of USA Operations
Lazarus has broad industry experience and a reputation for developing operational infrastructure and processes, building teams, and running P&Ls. She began her career at General Electric in the Manufacturing Management Program, and she went on to hold a variety of roles including General Manager of the Interventional Service business overseeing products in Cardiology, Angiography, Neurology, Electrophysiology & IT. She also led GE Healthcare’s Global Service Integration initiative before joining ArchPoint Consulting as a partner, later becoming managing director. There, her client focus included strategic planning, M&A, and post-merger integrations for companies in healthcare, pharma, energy, emergency services and advanced engineering materials. Lazarus holds an Executive M.B.A. from Northwestern’s Kellogg School of Management and a B.S. in industrial engineering from Georgia Tech.
Sean Finnerty, Area Vice President of Sales – East
Finnerty has worked for nearly 15 years in the medical device industry, holding senior sales leadership positions at both private and public companies. Prior to joining ControlRad, Finnerty was national sales manager at Cartiva, Inc., where he was responsible for the commercial launch of the first ever FDA-approved Synthetic Cartilage Implant for the treatment of great toe arthritis and was part of the leadership team that executed the acquisition by Wright Medical. Earlier in his career, Finnerty held sales leadership positions with Stryker, Carticept Medical, Inc, and Integra LifeSciences. He earned a Bachelor of Science degree from the United States Naval Academy and is a combat veteran.
Timothy Hein, Area Vice President of Sales – West
Hein has worked for more than 25 years in the medical device industry, holding senior sales leadership positions at both private and public companies. Before joining ControlRad, Hein was vice president of sales for Paradigm Spine until the company was acquired by RTI Surgical. Previously, he served as west area vice president of sales at LDR Spine and held sales leadership positions with Kyphon/Medtronic, Depuy Spine and Ethicon Endo-Surgery. He earned his bachelor’s degree from the United States Military Academy at West Point and Master of Business Administration from Pacific Lutheran University. He served as an active duty Army Officer for six years.
About ControlRad Trace
ControlRad Trace is the only technology that can be integrated into existing mobile C-arms to reduce radiation in any fluoroscopic imaging procedure. With its proprietary semi-transparent filter system, tablet and image processing technology, the ControlRad Trace solution can be retrofitted on existing C-arms, reducing the barrier to adopting the technology. The medical staff draws a region of interest (ROI) on the ControlRad tablet, which in real-time optimizes image quality in the ROI while reducing unnecessary radiation in the periphery.
ControlRad is a privately held medical technology company developing innovative products that dramatically reduce the radiation exposure from fluoroscopically guided procedures (FGP) for patients and healthcare professionals. ControlRad’s products are designed to improve safety without compromising image quality or workflow. They include an integrated set of proprietary components, which optimize the X-ray beam to deliver optimal image quality in the clinically relevant region while maintaining appropriate resolution in the periphery. ControlRad is headquartered in Atlanta, Georgia, and has engineering development facilities in Kfar Saba, Israel. To learn more about ControlRad and ControlRad Trace, visit www.ControlRad.com or email info@ControlRad.com.